The Leukemogenic TCF3-HLF Complex Rewires Enhancers Driving Cellular Identity and Self-Renewal Conferring EP300 VulnerabilityYun Huang, Jean‐Pierre Bourquin, Vyacheslav Amstislavskiy et al.|Cancer Cell|2019Cited by 63
Update on long-term outcomes of a cohort of patients with TCF3::HLF positive acute lymphoblastic leukemia treated with blinatumomab and stem cell transplantationAida Zečkanović, Jean‐Pierre Bourquin, Brice Mouttet et al.|Haematologica|2025Cited by 3
Illuminating the leukemogenic transformation activity of TCF3-HLF in pediatric ALLBrice Mouttet, Jean‐Pierre Bourquin, Yü Huang et al.|Klinische Pädiatrie|2017Cited by 0
A Flow and Metabolism-Based Drug Screening Platform for Liquid Patient Leukemia SamplesAlicia J. Kaestli, Kasper Renggli, Martina De Geus et al.|Unknown|2017Cited by 0
TCF3-Hlf Hijacks ERG to Activate Leukemia-Critical Super-Enhancers in t(17;19) LeukemiaYun Huang, Jean‐Pierre Bourquin, Brice Mouttet et al.|Blood|2017Cited by 0